Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Uterine Cervical Neoplasms 13Prostatic Neoplasms 6Sarcoma 4Breast Neoplasms 4Radiation Injuries 2Carcinoma, Ductal, Breast 2Obesity 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Fatigue 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Endometrial Clear Cell Adenocarcinoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Anemia 1

Interventions

Paclitaxel 4Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Mental Status and Dementia Tests 2Cisplatin 2Amifostine 2Vincristine 1Temozolomide 1Rituximab 1Procarbazine 1Methotrexate 1Memantine 1Magnetic Resonance Spectroscopy 1Diffusion Tensor Imaging 1Cytarabine 1Carboplatin 1Brachytherapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neurotoxicity Syndromes × Brachytherapy × Clear all
NCT00807768 2019-03-20

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

GOG Foundation

Phase 3 Unknown
601 enrolled 13 charts
Other

Fatigue, Obesity, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡